From Fiddaman Blog:
Saturday, December 24, 2016
Glaxo Has Dolin’s Bells Ringing
GlaxoSmithKline – The company that keeps on giving.
Glaxo have been dealth yet another blow in the Paxil suicide case filed by Wendy Dolin over 5 years ago.
To date Glaxo have made endless requests that have been denied by the Judge, they have tried to get expert witnesses barred from giving evidence and even wanted to hold their own kangaroo court for one of Dolin’s witnesses, David Healy – once again they were denied.
Their latest attempt is, or was, a wonderful attempt at skullduggery. It defies belief that they would try to even go down this particular route but, I guess, they have exhausted every possible line of trickery and manipulation so one final attempt before trial commences shouldn’t really come as a surprise to those who know exactly how Glaxo and their highly paid law team, King & Spalding, like to operate.
Some time ago Glaxo were informed by the Judge that they should not try to blind the jury in this case with irrelevant documents. The jury just need to know the facts and endless documents would just confuse them. So, what did Glaxo do on the back of this request from the Judge? Well, they submitted a 170 page exhibit list with roughly 1,500 proposed defense trial exhibits – so, no attempt at burying the jury in paper, right? (See Judge Backs Widow’s Objection To GSK Trial Documents)
The documents are hundreds of pages long and, according to Dolin, if printed out would fill more than 20 bankers’boxes.
Wendy Dolin, through her law team, Baum Hedlund Aristei & Goldman PC, objected to the mountain of paperwork and the Judge, U.S. District Judge William T. Hart, has sustained her objections, leaving Glaxo and King & Spalding with their tails between their legs and having to spend Christmas with the knowledge that they cannot dupe the Judge or jury in this case.
Better luck next time folks (I’m sure there will be another Paxil related suicide case to defend)
Furthermore, GSK objected to evidence being presented to the jury by Dolin, namely, correspondence between Glaxo and the FDA. The Judge denied them this and many other objections they had filed regarding Dolin’s evidence to be presented – (Boo-hoo)
The antics of Glaxo and their crispy white shirts has prompted yet another ditty from yours truly. I hope Glaxo and King & Spalding enjoy this latest offering.
DOLIN’S JINGLE BELLS